{"title":"[Simultaneous determination of salidroside and tyrosol in Beagle dog plasma using UHPLC-MS/MS after pre-column dansyl chloride derivatization].","authors":"Shuai Chen, Yuan-yuan Xia, Guang-li Wei, Quan-sheng Li, Meng-jie Liu, Yong Chen, Duan-yun Si","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A pre-column derivatization method combined with UHPLC-MS/MS was developed for the\nsimultaneous determination of salidroside and tyrosol in Beagle dog plasma. After protein precipitation by\nacetonitrile, the liquid supernatant was treated with dansyl chloride under dark conditions at 60 ℃ for 30 min,\nand then, the sample solution was extracted using methyl tertiary butyl ether. The multiple reaction monitoring\nin positive ion mode was used for MS detection of the tested analytes with the specific ion transitions of\nm/z 534.2→372.0 for salidroside derivative, m/z 372.0→171.0 for tyrosol derivative and m/z 506.0→171.0 for\narbutin derivative. The chromatograph separation was achieved on an ACQUITY UPLC® BEH C18 column\n(100 mm × 2.1 mm, 1.7 μm) with a gradient mobile phase consisting of acetonitrile (0.1% formic acid)-water\n(10% acetonitrile, 0.1% formic acid) for 9 min. The assay showed a good linearity over the range of 0.02/0.1 −\n20/10 μmol·L−1 with a lower limit of quantitation of 0.02 and 0.1 μmol·L−1 for salidroside and tyrosol in dog\nplasma, respectively. The intra- and inter-day precisions were all less than 8.68%, and the accuracy was within\n±11.4%. The established method with a high sensitivity, good specificity and reliability was appropriate for\nsimultaneous determination of salidroside and tyrosol in dog plasma and successfully applied to a pharmacokinetic\nstudy after intragastric administration of salidroside to Beagle dogs.</p>","PeriodicalId":35924,"journal":{"name":"药学学报","volume":"52 2","pages":"296-301"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"药学学报","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A pre-column derivatization method combined with UHPLC-MS/MS was developed for the
simultaneous determination of salidroside and tyrosol in Beagle dog plasma. After protein precipitation by
acetonitrile, the liquid supernatant was treated with dansyl chloride under dark conditions at 60 ℃ for 30 min,
and then, the sample solution was extracted using methyl tertiary butyl ether. The multiple reaction monitoring
in positive ion mode was used for MS detection of the tested analytes with the specific ion transitions of
m/z 534.2→372.0 for salidroside derivative, m/z 372.0→171.0 for tyrosol derivative and m/z 506.0→171.0 for
arbutin derivative. The chromatograph separation was achieved on an ACQUITY UPLC® BEH C18 column
(100 mm × 2.1 mm, 1.7 μm) with a gradient mobile phase consisting of acetonitrile (0.1% formic acid)-water
(10% acetonitrile, 0.1% formic acid) for 9 min. The assay showed a good linearity over the range of 0.02/0.1 −
20/10 μmol·L−1 with a lower limit of quantitation of 0.02 and 0.1 μmol·L−1 for salidroside and tyrosol in dog
plasma, respectively. The intra- and inter-day precisions were all less than 8.68%, and the accuracy was within
±11.4%. The established method with a high sensitivity, good specificity and reliability was appropriate for
simultaneous determination of salidroside and tyrosol in dog plasma and successfully applied to a pharmacokinetic
study after intragastric administration of salidroside to Beagle dogs.
药学学报Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.20
自引率
0.00%
发文量
0
期刊介绍:
Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent advances. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953. The journal is co-published by Elsevier B.V., in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.